| SeoulTech-KIRAMS 의과학대학원
학술세미나
[01811] 서울 노원구 공릉로 232 서울과학기술대학교
창조관 309호(전문대학원 통합사무실)
TEL : 02-970-6816
copyright(c) SEOUL NATIONAL UNIVERSITY OF SCIENCE AND TECHNOLOGY. All rights resesrved.
□ 일시: 2026. 1. 23.(금), 11:00~17:00
□ 장소: 한국원자력의학원 국가RI신약센터 5층 대회의실
□ 내용
▷ SeoulTech-KIRAMS 의과학 교육 프로그램 [김길호 원우회장]
▷ SeoulTech-KIRAMS 의과학대학원 발전 방향 [박진원 교수, 서울과학기술대학교 의과학대학원]
▷ 임상문제에서 연구주제 찾기 "의사-과학자의 Translational Research 접근" [박동준 교수, 서울대학교 의과대학]
▷ ‘화생방핵 및 폭발’ 관련 특수재난 대응을 위한공공의료 전담 의사의 육성에 관한 전략 마련 [조민수 센터장, 한국원자력의학원]
▷ 우주방사선의 인체영향과 의학적 관점 [장원일 과장, 한국원자력의학원]
□ 일시: 2025. 10. 28.(화), 18:00
□ 장소: 상상관 108호
□ 강연: Young Charles Jang. Ph.D. (Associate Professor, School of Medicine at Emory University and School of Biological Sciences, Georgia Institute of Technology)
□ 주제: Towards Medicine 3.0: Recent Advances in Geroscience Technology and Regenerative Medicine (Medicine 3.0을 향하여: 제로사이언스 기술과 재생의학의 최신 발전)
□ 내용: AI·유전체 기반의 개인맞춤형 예방의학으로, 노화 기전을 겨냥한 제로사이언스와 재생의학 기술을 결합해 건강수명과 삶의 질을 극대화하는 차세대 의료 패러다임 Medicine 3.0 소개
Medicine 3.0 embodies a paradigm shift from reactive, disease-centered care toward proactive, personalized, and longevity-focused health strategies. At its core is personalized medicine, leveraging genomics, multi-omics, digital health platforms, and AI-driven analytics to tailor prevention and treatment to individual biological profiles. Within the realm of aging, geroscience, which connects the biology of aging to chronic disease, provides the conceptual framework to delay, attenuate, or even reverse the molecular hallmarks of aging. In this presentation, I will highlight emerging geroscience technologies, including single-cell multi-omics, senescence profiling, wearable health monitoring, organoid and 3D microphysiological system modeling, and in vivo cellular reprogramming, which together offer unprecedented capabilities to dissect age-related decline and design targeted interventions. Parallel advances in regenerative medicine, such as stem cell engineering, biofunctional materials, 4D tissue bioprinting, and nextgeneration gene-editing, are restoring tissue and organ function compromised by aging or age-associated diseases. Together, these innovations define Medicine 3.0 as a holistic and integrative practice, aiming not only to extend lifespan but also to enhance healthspan, delaying frailty, preserving independence, and improving quality of life in aging populations. By converging personalized precision tools with geroscience-driven interventions and regenerative platforms, Medicine 3.0 sets the stage for a nextgeneration healthcare ecosystem built on resilience, prevention, and longevity.